January 18, 2023
Pathalys Pharma Raises $150 Million in Secured Product Financing and Equity led by Abingworth; Forms Strategic Collaboration with Launch Therapeutics to Advance Upacicalcet through Pivotal Phase 3 Studies
Read More
March 28, 2022 Aculys Pharma Closes US$24 Million…
Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Fujisawa City, Kanagawa Prefecture, Representative Director and CEO: Kazunari Tsunaba), a new biopharmaceutical company focused on the development and …
Continue reading “Aculys Pharma Closes US$24 Million Series B Financing”

March 10, 2022 Catalys Pacific Calls for Economical…
Catalys Pacific would like to inform that we have signed onto an open letter to call for the global business community to economically disengage from …
Continue reading “Catalys Pacific Calls for Economical Disengagement from Russian Industry”

April 6, 2021 Mineralys Therapeutics Closes $40 Million…
PHILADELPHIA, PA, April 6, 2021 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific, announced today that the Company completed a …
Continue reading “Mineralys Therapeutics Closes $40 Million Series A Funding”